Update in Vitreoretinal Instrumentation

Abstract

Disclosures: Gerardo González-Saldivar has nothing to declare in relation to this article. David R Chow declares the following financial interests or relationships: consultant/advisor for Alcon Laboratories, Inc., Bayer Healthcare Pharmaceuticals, Dutch Ophthalmic Research Center (DORC) International USA and Katalyst; lecture fees for DORC International USA, OptoVue and Allergan; and equity ownership/stock options in public or privately traded firms, excluding mutual funds from Katalyst and Synergetics, Inc.